Skip to content

Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS

A RANDOMIZED, CONTROLLED, CLINICAL TRIAL TO COMPARE PERIPHERAL PARENTERAL NUTRITION (PeriOlimel N4-E) VERSUS CONVENTIONAL FLUID THERAPY IN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN COLORECTAL CANCER SURGERY.

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03606863
Enrollment
200
Registered
2018-07-31
Start date
2016-10-31
Completion date
2019-04-30
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Fast-track, Parenteral Nutrition

Brief summary

Assess if administration of early nutrition support with Perioperative Peripheral Nutrition (PeriOliclimonel) N4-E) in patients undergoing colon cancer resection in an Enhanced Recovery After Surgery (ERAS) Protocol improve the results of morbi-mortality and hospitalization versus standard intravenous fluid therapy.

Detailed description

The main objective is to determine if perioperative nutritional support with PeriOlimel N4-E, that reaches nutritional requirements of ERAS protocol for colorectal cancer surgery patients, can improve nutritional status so it decreases postoperative complications, hospital length of stay and costs, compared to conventional fluid therapy administration since patients receive oral nutrition at day 3-5.

Interventions

DRUGPerioperative peripheral parenteral nutrition

Sponsors

Antonio Arroyo Sebastian
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* scheduled colorectal cancer surgery * ASA I-IV

Exclusion criteria

* Emergency surgery * Distant metastasis * Patient´s refusal to participate * Allergy or hypersensitivity to egg or soy protein * Advanced kidney or hepatic impairment * Severe bleeding disorders * Congenital abnormalities of amino acid metabolism * Hyperlipidemia and severe or difficult to control hyperglycemia

Design outcomes

Primary

MeasureTime frameDescription
morbi-mortality30 daysEarly Peripheral Parenteral Nutrition in patients undergoing colon cancer resection in an Enhanced Recovery After Surgery Protocol to improve the results of morbi-mortality and hospitalization versus standard intravenous fluid therapy

Countries

Spain

Contacts

Primary ContactAntonio Arroyo, MD
arroyocir@hotmail.com966 616 000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026